GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enzymatica AB (XSAT:ENZY) » Definitions » Ending Cash Position

Enzymatica AB (XSAT:ENZY) Ending Cash Position : kr26.92 Mil (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Enzymatica AB Ending Cash Position?

Enzymatica AB's Ending Cash Position for the quarter that ended in Mar. 2024 was kr26.92 Mil.

Enzymatica AB's quarterly Ending Cash Position declined from Sep. 2023 (kr13.02 Mil) to Dec. 2023 (kr8.37 Mil) but then increased from Dec. 2023 (kr8.37 Mil) to Mar. 2024 (kr26.92 Mil).

Enzymatica AB's annual Ending Cash Position increased from Dec. 2021 (kr31.62 Mil) to Dec. 2022 (kr50.69 Mil) but then declined from Dec. 2022 (kr50.69 Mil) to Dec. 2023 (kr8.37 Mil).

Enzymatica AB Ending Cash Position Historical Data

The historical data trend for Enzymatica AB's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzymatica AB Ending Cash Position Chart

Enzymatica AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.32 24.02 31.62 50.69 8.37

Enzymatica AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.42 29.12 13.02 8.37 26.92

Enzymatica AB Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Enzymatica AB's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=50.689+-42.323
=8.37

Enzymatica AB's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=8.365+18.559
=26.92

Enzymatica AB Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Enzymatica AB's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Enzymatica AB (XSAT:ENZY) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enzymatica AB (XSAT:ENZY) » Definitions » Ending Cash Position
Comparable Companies
OSTO:ORX XSAT:EQL OSTO:ALZCUR OSTO:MOB OSTO:ERMA OSTO:CRNO B OSTO:VIVE XSAT:PMED XSAT:ODI XSAT:DICOT ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
ENZY:Sweden EN9:Germany
Address
Scheelevagen 19, Delta 5, Ideon Science Park, Lund, SWE, SE-223 70
Website
http://www.enzymatica.se
Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period.

Enzymatica AB (XSAT:ENZY) Headlines

From GuruFocus

Julian Robertson Cuts Half of Stake in Paulson-Backed Company

By Holly LaFon Holly LaFon • 07-01-2016

Julian Robertson Adds to Multiple Positions in 3rd quarter

By Tiziano Frateschi Tiziano Frateschi • 12-20-2016

Tiger Management Founder Julian Robertson Ups Stake in Enzymotec

By Kyle Ferguson Kyle Ferguson • 12-07-2015